Facts
as of Nov 17, 2026
Beam Therapeutics is an American biotechnology company developing precision genetic medicines based on base editing, a gene editing technology designed for precise, predictable changes to DNA. It combines gene editing, delivery and in-house manufacturing in an integrated platform aimed at lifelong cures for serious diseases. The company is headquartered in Cambridge, Massachusetts.
It is hiring: 13 open roles, 2 of them posted in the last 30 days. Its stated pay is 13% above the market estimate for the same roles.
- Legal name
- Beam Therapeutics Inc.
- Headquarters
- Cambridge, United States
- Founded
- 2002
- Employees
- 479US Form 5500 (plan participants) · Dec 2024
- Listing
- NASDAQ: BEAM
- Open roles
- 13 in 2 citiesAlion job postings
- Register numbers
- NAME beam therapeutics inc
- Website
- beamtx.com
As of Nov 17, 2026, Alion lists 13 open roles at Beam Therapeutics. Beam Therapeutics is headquartered in Cambridge, United States. It was founded in 2002. The median pay stated in its open roles is $225k, across 13 postings that state pay.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Beam Therapeutics Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring slowly: few roles were posted lately.
Analytics is the largest family, 14 of open roles.
2Posted in 30 days13% of open roles are fresh
7%Remote roles1 of 15
2Hiring offices
Can they hire you from United States?by your location
Likely
24 open roles are in your country: you apply locally, no move needed.
United States24On site
Remote, from elsewhere1Rare
No posting offers visa sponsorship. Remote roles: 1.
Time to fillmedian days to close a role
Beam Therapeutics47 days
Market, same roles30 days
Alion signals0-100
Demand38
Pay25
Your chance52
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 11 then, 0 now
Where the openings areshare of open roles · trend
Analytics14▲
Early Careers14▼
Finance9▼
HR9▼
Sales9▼
Industrial Engineering9▼
Degree asked
Bachelor's Degree 83%Master's Degree 8%Doctoral Degree (PhD) 8%
Experience asked: 11.1 years on average, in 11 postings. 12 postings state a degree.
Benefits named in postingsshare of open roles
Contract type
Internship 1
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Pays 13% above the market estimate for the same roles.
$205kMedianmarket estimate $200k
$74k – $260kTypical rangeUSD a year
$320kHighest paying roleSenior Corporate Counsel, Corporate and Securities
Pay by levelmiddle half of stated pay, median marked · dashed: market median $200k
Senior3$185k
Head+7$260k
$0$75k$150k$225k$300k
Source: the pay stated in the company's postings, normalised to USD a year
Named in the work visa registers of United States.
9 ▼ 25%H-1B filings in 12 months
3Green card filings
$130kMedian offered salary
In the register as Beam Therapeutics, Inc., Cambridge, MA (+1 more)
Other sponsors in the same field
US Department of Labor · latest filing Jun 17, 2026
Footprint
Hiring in 2 cities in 1 country.
2Cities
1Countries
CambridgeBusiest site
Source: office addresses in postings and company registers
Ranked #6 by open roles among its 11 closest peers.
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)
Technologies named in job postings at Beam Therapeutics over the last 12 months, by layer, with the share of postings for each.
13Technologies in use
11Postings analysed
59/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Milestones
Each milestone is dated by its source: registers, filings, the press
Newsroom
top 0.37%Web presenceof 133.2M domains by links, Common Crawl
Sep 242026
News · YahooFinance
Beam Therapeutics sits in a crowded gene editing field, and its share price history raises a simple question for you as an investor: Is the current US$24.37 price properly reflec…
Sep 82026
News · markets.businessinsider.com
BEAM-302 Continues to Demonstrate Potential as One-time Treatment for Both Lung and Liver Manifestations of AATD, with AAT Protein Production Unde...
Aug 312026
News · markets.businessinsider.com
CAMBRIDGE, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic ...
Apr 112026
News · The Motley Fool
This precision genetic medicine developer reported a notable insider sale as it advances therapies for rare and serious diseases.
Sources: the outlets named on each headline, each story once